drugset / Trial / NCT01754714

Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group

NCT01754714

Phase 3 Completed 108 enrolled Abbott PPD Development, LP · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Investigation the Effects of Different Doses of SAMe in Subjects with Nonalcoholic Fatty Liver Disease and non-treated matched healthy volunteers as control group

Timeline

Start
2012-12
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ademetionine Unknown 1000 mg
Subject Ademetionine Unknown 1500 mg
Subject Ademetionine Unknown 2000 mg

Indications